Erle Mast Insider Profile
4 Followers
Erle Mast, Director at Sienna Biopharmaceuticals, holds ― shares in Sienna Biopharmaceuticals (Ticker: SNNAQ), holds 3.03K shares in Zogenix (Ticker: ZGNX), holds 135.58K shares in Clovis Oncology (Ticker: CLVSQ).
Erle Mast's Trading History
| ZGNXZogenix | Nov 26, 2018 | ― | Informative Sell | 61.76K | $80.76K | |
| CLVSQClovis Oncology | Nov 03, 2015 | ― | Uninformative Sell | 316.67K | $2.03K | |
| RCPTReceptos | Aug 27, 2015 | ― | Uninformative Sell | ― | $0.00 | |
| SOMXSomaxon Pharmaceuticals | ― | ― | ― | ― | ||
| SNNAQSienna Biopharmaceuticals | ― | Director | ― | ― |
You May Also Like
Erle Mast insider profile FAQ
What is the percentage of profitable transactions made by Erle Mast?
The percentage of profitable transactions made by Erle Mast is 50%.
What is the average return per transaction made by Erle Mast?
The average return per transaction made by Erle Mast is 90.30%.
What stocks does Erle Mast hold?
Erle Mast holds: SNNAQ, CLVSQ, ZGNX, RCPT, SOMX stocks.
What was Erle Mast's most profitable transaction?
Erle Mast’s most profitable transaction was an Informative Buy of RCPT stock on March 17, 2014. The return on the trade was 193.10%.
What is Erle Mast's role in Sienna Biopharmaceuticals?
Erle Mast's role in Sienna Biopharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
